Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin Mutation. (2019)

First Author: Orlans HO
Attributed to:  Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1167/iovs.19-26964

PubMed Identifier: 31247114

Publication URI: http://europepmc.org/abstract/MED/31247114

Type: Journal Article/Review

Volume: 60

Parent Publication: Investigative ophthalmology & visual science

Issue: 7

ISSN: 0146-0404